X
XLinkedinWhatsAppTelegramTelegram
0

European Union - Commission clears acquisition of anial health assets of Pfizer by Eli Lilly&Co

The European Commission has granted clearance under the EU Merger Regulation to the acquisition of animal health assets of Pfizer by Eli Liily & Co, both of the USA.
27 May 2010
X
XLinkedinWhatsAppTelegramTelegram
0
The European Commission has granted clearance under the EU Merger Regulation to the acquisition of animal health assets of Pfizer by Eli Liily & Co, both of the USA.

Eli Lilly is a research based, global pharmaceutical company engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products for humans and animals. Pfizer is active in the production of vaccines for animals. The operation was examined under the simplified merger review procedure.

http://europa.eu/rapid/pressReleasesAction.do?reference=MEX/10/0525&format=HTML&aged=0&language=EN&guiLanguage=ca

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list pig333.com in 3 minutes

Weekly newsletter with all the pig333.com updates

Log in and sign up on the list